Valeant Pharmaceuticals International, Inc. has extended the expiration of its exchange offer to acquire all of the outstanding shares of Allergan, Inc. to December 31, 2014. The exchange offer was previously scheduled to expire  August 15, 2014. All other terms and conditions of the exchange offer remain unchanged.

Valeant Pharmaceuticals made an unsolicited $53 billion takeover bid for Allergan in June 2014 following rejection by Allergan of earlier offers by Valeant to acquire the company.

Source: Valeant Pharmaceuticals